Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
Price:
61.75
CNY
-3.82%
Market Closed
Market Cap:
¥4.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
|
CN |
|
Novartis India Ltd
NSE:NOVARTIND
|
IN |
|
E
|
Energa SA
WSE:ENG
|
PL |
|
G
|
Galp Energia SGPS SA
ELI:GALP
|
PT |
|
SSC Security Services Corp
XTSX:SECU
|
CA |
|
Sunyes Electronic Manufacturing Guangdong Holding Co Ltd
SZSE:002388
|
CN |
|
H
|
Healthpeak Properties Inc
F:HC5
|
US |
|
Zalando SE
XETRA:ZAL
|
DE |
|
M
|
MPDaesan Inc
KOSDAQ:065150
|
KR |
Multiples-Based Value
The Multiples-Based Value of one
Medprin Regenerative Medical Technologies Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 61.75 CNY,
Medprin Regenerative Medical Technologies Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Medprin Regenerative Medical Technologies Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Medprin Regenerative Medical Technologies Co Ltd Competitors
Medprin Regenerative Medical Technologies Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
|
4.1B CNY | 12.2 | 40.3 | 34.7 | 34.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.6B USD | 4.1 | 27.7 | 15.9 | 21.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
160.7B USD | 16 | 56.3 | 42.6 | 52.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.2B USD | 5 | 38.6 | 19.7 | 23.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD | 3.2 | 24.2 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
102.6B USD | 5.1 | 35.4 | 20.8 | 28 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.1B USD | 7.6 | 43 | 23.6 | 25.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41B EUR | 1.7 | 19.1 | 10.8 | 15.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.5B USD | 10.3 | 42 | 29.8 | 33 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44B USD | 2 | 25 | 9.9 | 16.8 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
31.6B USD | 1.5 | 15.1 | 11 | 13.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
